on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released an opening position disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure relates to their interest in Mural Oncology plc. As of September 24, 2025, Vanguard holds 646,536 ordinary shares in Mural Oncology, representing 3.74% of the relevant securities.
The disclosure document indicates that there have been no significant dealings in cash-settled or stock-settled derivatives, nor any options or agreements to buy or sell additional securities. Additionally, Vanguard has conducted a sale of 32 ordinary shares at a price of 2.09 USD per unit.
No indemnity, agreements, or arrangements related to options or derivatives have been reported. Vanguard specifies no related voting rights agreements concerning the securities mentioned. No Supplemental Form 8 accompanied this disclosure.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news